Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
Learn how the Oncotype DX DCIS Score predicts recurrence and adds treatment options in early-stage breast cancer.
If you have been diagnosed with early-stage breast cancer and are exploring your treatment options, learn why axillary surgery may not be necessary.
NEW YORK (Reuters Health) - About one third of breast cancer survivors experience fatigue that can affect their quality of life, but a small new study finds that doing yoga might help restore some lost vitality.
NEW YORK (Reuters Health) - In a new survey of breast cancer survivors, few people said that having a follow-up appointment with a doctor or nurse over the phone or online instead of in person would ease their stress and worry.
NEW YORK (Reuters Health) - Women treated for breast cancer with radiation with or without chemotherapy had more thinking and memory problems a few years after their treatment ended than women who'd never had cancer, in a new study.
(Reuters) - Women who get a quicker, localized form of radiation treatment for early-stage breast cancer are more likely to need to have their breast removed later on than women treated with traditional radiation of the whole breast.
NEW YORK (Reuters Health) - The outlook for breast cancer patients carrying variant versions of the BRCA genes is a subject of debate, but a new study suggests those women do just as well as patients with similar cancers, as long as they follow standard treatments.
If you have been diagnosed with HER2 positive, early-stage breast cancer, find out how you and your healthcare team can reduce the risk of heart-damaging side effects potentially caused by some chemotherapy treatments.
NEW YORK (Reuters Health) - Despite concerns that removing both of a woman's ovaries would raise her chances of dying from diseases associated with aging, a large new study suggests the procedure may be safe.
WASHINGTON (Reuters) - U.S. drug regulators on Friday withdrew approval of Roche's Avastin as a treatment for breast cancer, capping a protracted and emotional battle over a drug backed by many survivors of the disease.